Skip to content

PeerfordResearch intelligence

Countries
Institutions
Researchers
Fields
Rankings
Compare
Commons

Search institutions, scholars, countries and publications

Countries
Institutions
Researchers
Fields
Rankings
Compare

CommonsWhere researchers talk about their work

Search institutions, scholars, countries and publications

Every figure here is counted by Peerford from the works themselves, the same way for every institution.

Browse

Countries
Institutions
Researchers
Fields
Rankings
Commons, for researchers

About

How Peerford counts
Compare institutions
Privacy
Terms of use

Contact

hello@peerford.com
https://wa.me/peerford · WhatsApp

Language

English
FrançaisFrench
PortuguêsPortuguese
العربيةArabic

Theme

SystemLightDark

Maame Anima Attobrah Sarfo · Peerford

Kwame Nkrumah University of Science and Technology / Scholars

MS

Maame Anima Attobrah Sarfo

Kwame Nkrumah University of Science and Technology

Publishing since 2022, latest 2025

Immunology
Public Health, Environmental and Occupational Health
Health

Their record on OpenAlex
Download CV:PDF Word
Who they write with Where their co-authors are Every publication
Is this you? Sign in to edit your profile

Publications: 32022–2025
Citations: 82to those papers
h-index: 3i10-index 1
Field-weighted impact: 5.641.00 is the world average
World top 10%: 67%2 of 3 scored papers
Open access: 100%3 papers free to read

By year

Papers, and the citations to them

Publications, left axisCitations to that year’s papers, right axis2026 still in progress

Citations received each year

Peerford

To all their work, old papers included. Google Scholar also counts citations from theses, books and web pages, so its line runs higher.

What they work on

From the classification of each paper

Subfields

Immunology3100%

Career

On their papers

Presbyterian University, Ghana3 works
Kwame Nkrumah University of Science and Technology3 works

Every institution they have given on a paper.

Publications

3 in all

Newest Most cited Oldest Title

Search their publications by title

Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial
2025The Lancet Global HealthJournalOpen access3 citations10.1016/s2214-109x(25)00272-4
Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine

Public Health, Environmental and Occupational Health3100%

Health133%

Health Sciences
Life Sciences
Social Sciences

Topics most written on

Immune responses and vaccinations3
Malaria Research and Control3
Mosquito-borne diseases and control2
Vaccine Coverage and Hesitancy1

Who they write with

Their most frequent co-authors, and the papers those co-authors share

Where their co-authors are

100% of their papers have a co-author abroad

papers co-written3333333Home

Most frequent partner countries

United States3
Belgium3
Kenya3

Papers with at least one author in that country.

Institutions written with most

Centers for Disease Control and PreventionUS3 papers
Division of Parasitic Diseases and MalariaUS3 papers
Kenya Medical Research InstituteKE3 papers
Centers for Disease Control and PreventionKE3 papers
Presbyterian University, GhanaGH3 papers
Program for Appropriate Technology in HealthUS2 papers
Center for Global HealthUS1 paper
National Center for Emerging and Zoonotic Infectious DiseasesUS1 paper

Where they publish

The Journal of Infectious Diseases1
The Lancet Global Health1
The Lancet Infectious Diseases1

How it can be read

100% free to read

Gold 1 · 33%In an open-access journal
Hybrid 2 · 67%Open in a subscription journal

Who funds it

3 of 3 papers name a funder

Bill and Melinda Gates Foundation2
Bundesministerium für Bildung und Forschung2
GlaxoSmithKline2
National Institutes of Health2
PATH2
Kenya Medical Research Institute1

Development goals addressed

From each paper’s title and abstract

3Good health and well-being2

Most cited

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial
The Lancet Infectious Diseases3
202275 citationsWorld top 10%Open access · Hybrid
Could Less Be More? Accounting for Fractional-Dose Regimens and Different Number of Vaccine Doses When Measuring the Impact of the RTS,S/AS01E Malaria Vaccine
The Journal of Infectious Diseases3
20244 citationsOpen access · Hybrid
Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial
The Lancet Global Health
20253 citationsWorld top 10%Open access · Gold

2024The Journal of Infectious DiseasesJournalOpen access4 citations10.1093/infdis/jiae075

Efficacy of RTS,S/AS01E malaria vaccine administered according to different full, fractional, and delayed third or early fourth dose regimens in children aged 5–17 months in Ghana and Kenya: an open-label, phase 2b, randomised controlled trial

2022The Lancet Infectious DiseasesJournalOpen access75 citations10.1016/s1473-3099(22)00273-0